We have a long-standing research trajectory in genetic analysis of human populations in biomedicine and human molecularanthropology.
Where do we come from?
A. Salas Ellacuriaga is a Professor at the Universidade de Santiago de Compostela (USC), and a member of the Instituto de Medicina Legal (INCIFOR). His research activity began at the INCIFOR (previously IML) in 1994. Most of his research activity at that time was dedicated to human population genetics. The group was born at the same time his IP began his independent research career (PhD in 1999). The IP was the beneficiary of a 'tenure track' Ramón y Cajal contract (2005), and shortly afterward he stabilized as full Prof. at the Faculty of Medicine - USC. GenPoB, as it is conceived today, was born at the same time the Institute of Health Research (Instituto de Investigación Sanitaria - IDIS) was created (2008).
What are we?
The present conformation of the group emerges as a collaborative effort with GenViP (Genetics, Vaccines, Infectious Diseases and Pediatrics; GENVIP – IDIS) head by F. Martinón Torres (Head of Pediatrics - Hospital Clínico) and A. Salas Ellacuriaga. We met >14 ya and now work together in a variety of projects related to human populations with a special focus on infectious diseases and vaccines. We established a synergistic collaboration that combined basic (GenPoB) and clinical/translational science (Genvip). We now carry out basic research with an eye put on translational, personal and precision medicine. Besides, we work very close to other IDIS research laboratories and within a broad and complex international collaboration network.
Where are we going?
In the last 10 years or so, the main interest of GenPoB has switched to 'omics'. We still dedicates effort to do research in different aspects of forensic genetics related to human population variation. A few keywords help at summarizing the research activity of GenPoB today: human genomics, next generation sequencing, whole genome and whole exome sequencing, transcriptomics, epigenomics, bioinformatics, infectomics, vaccinomics, common and rare diseases. See also the Lab section.
Rare disease day 2020
28 de Febrero de 2020
We celebrated the international rare disease in our group by organizing didactic presentations to the hospitalized children. Place: school of the Hospital Clínico Universitario of Santiago de Compostela. [Read more]
A primary school from Noia (Galicia, Spain) visiting our lab
6 de Marzo de 2020
We really enjoyed to share the time with the children! Nice opportunity to explain future researchers how research works! They had the opportunity to extract DNA from strawberries, pipetting, etc.We used music (Mozart...) to explain to the childre... [Read more]
I International Zenda awards to our group
27 de Noviembre de 2019
GenViP visiting the biotecnological Zendal installations the day we received the I International Zendal Awards.GenViP received the I International Zenda Award. Federico Martinón Torres and Antonio Salas Ellacuriaga got the award on behalf of the r... [Read more]
European project: Diamonds - H2020
21 de Enero de 2020
La Voz de Galicia: Una prueba rápida permitirá diagnosticar una meningitis o una neumonía en menos de dos horas. El laboratorio GenVip del hospital de Santiago reclutará a 5.000 pacientes de toda Europa para establecer la firma genética que posibi... [Read more]
nCounter - Nanostring
3 de Enero de 2020
Visit our web-site: https://nanostringenvip.comhttps://www.linkedin.com/posts/nanostringenvip_servicio-nanostring-de-genvip-activity-6636632596669435904-7dsRDid you know that n-counter nanostring technology is one of the most robust that exists to... [Read more]